High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters

Immunity

Volumn 5, Issue 5, 1996, Pages 479-489

  Himes, S Roy ^a   Coles, Leeanne S ^a   Reeves, Raymond ^b   Shannon, M Frances ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; COMPLEMENTARY RNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; TRANSCRIPTION FACTOR;

ARTICLE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030294284     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80503-8     Document Type: Article

References (54)

1. Abdulkadir, S.A., Krishna, S., Thanos, D., Maniatis, T., Strominger, J.L., and Ono, S.J. (1995). Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression. J. Exp. Med. 182, 487-500.
2. Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S., and Baltimore, D. (1995). Embryonic lethality and liver degeneration in mice lacking the ReIA component of NF-κB. Nature 376, 167-170.
3. Bryan, R.G., Li, Y., Lai, J.H., Van, M., Rice, N.R., Rich, R.R., and Tan, T.H. (1994). Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells. Mol. Cell. Biol. 14, 7933-7942.
4. Chuvpilo, S., Schomberg, C., Gerwig, R., Heinfling, A., Reeves, R., Grummt, F., and Serfling, E. (1993). Multiple closely linked NFAT/ octamer and HMG I(Y) binding sites are part of the interleukin 4 promoter. Nucl. Acids Res. 21, 5694-5704.
5. Disney, J.E., Johnson, K.R., Magnuson, N.S., Sylvester, S.R., and Reeves, R. (1989). High mobility group protein HMG-I localizes to G/Q and C-bands of human and mouse chromosomes. J. Cell Biol. 109, 1975-1982.
6. Du, W., and Maniatis, T. (1994). The high mobility group protein HMG I(Y) can stimulate or inhibit binding of distinct transcription factor ATF-2 isoforms. Proc. Natl. Acad. Sci. USA 91, 11318-11322.
7. Du, W., Thanos, T., and Maniatis, T. (1993). Mechanism of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 74, 887-898.
8. Dunn, S.M., Coles, L.S., Lang, R.K., Gerondakis, S., Vadas, M.A., and Shannon, M.F. (1994). Requirement for nuclear factor (NF)-κB p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter. Blood 83, 2469-2479.
9. Falvo, J.V., Thanos, D., and Maniatis, T. (1995). Reversal of intrinsic DNA bends in the IFNβ gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 83, 1101-1111.
10. Fraser, J.D., and Weiss, A. (1992). Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28. Mol. Cell. Biol. 12, 4357-4363.
11. Fraser, J.D., Irving, B.A., Crabtree, G.R., and Weiss, A. (1991). Regulation of interleukin-2 gene enhancer activity by the T-cell accessory molecule CD28. Science 251, 313-316.
12. Friedmann, M., Holth, L.T., Zoghbi, H.Y., and Reeves, R. (1993). Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucl. Acids Res. 21, 4259-4267.
13. Gerondakis, S., Strasser, A., Metcalf, D., Grigoriadis, G., Schreerlinck, J.-P.Y., and Grumont, R.J. (1996). Rel-deficient T cells exhibit defects in the production of interleukin 3 and GM-CSF. Proc. Natl. Acad. Sci. USA 93, 3405-3409.
14. Ghosh, P., Tan, T.-H., Rice, N.R., Sica A., and Young, H.A. (1992). The interleukin-2 CD28 responsive complex contains at least three members of the NF-κB family: c-Rel, p50, and p65. Proc. Natl. Acad. Sci. USA 90, 1696-1700.
15. Ghosh, P., Sica, A., Cippitelli, M., Subleski, J., Lahesmaa, R., Young, H.A., and Rice, N.R. (1996). Activation of nuclear factor of activated T cells in a cyclosporin A-resistant pathway. J. Biol. Chem. 271, 7700-7704.
16. Gimmi, C.D., Freeman, G.J., Gribben, J.G., Sugita, K., Freedman, A.S., Morimoto, C., and Nadler, L.M. (1991). B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 88, 6575-6579.
17. Gorman, C.M., Moffat, L.F., and Howard, B.H. (1982). Recombinant genomes which express chloramphenicol acetyl-transferases in mammalian cells. Mol. Cell. Biol. 2, 1044-1051.
18. Green, J.M., Noel, P.J., Sperling, A.I., Walunas, T.L., Gray, G.S., Bluestone, J.A., and Thompson, C.B. (1994). Absence of B7-dependent responses in CD28-deficient mice. Immunity 1, 501-508.
19. Grumont, R.J., and Gerondakis, S. (1994). The subunit composition of NF-κB complexes changes during B-cell development. Cell Growth Differ. 5, 1321-1331.
20. Harlow, E., and Lane, D. (1988). Antibodies: A Laboratory Manual, E. Harlow and D. Lane, eds. (Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press), pp. 511-551.
21. Himes, S.R., Coles, L.S., Katsikeros, R., Lang, R.K., and Shannon, M.F. (1993). HTLV-1 tax activation of the GM-CSF and G-CSF promoters requires the interaction of NF-κB with other transcription factor families. Oncogene 8, 3189-3197.
22. Himes, S.R., Katsikeros, R., and Shannon, M.F. (1996). Costimulation of cytokine gene expression in T cells by the human T leukemia/ lymphotropic virus type 1 transactivator tax. J. Virol. 70, 4001-4008.
23. Hughes, C.W., and Pober, J.S. (1996). Transcriptional regulation of the interleukin-2 gene in normal human peripheral blood T cells. J. Biol. Chem. 271, 5369-5377.
24. John, S., Reeves, R.B., Lin, J.X., Child, R., Leiden, J.M., Thompson, C.B., and Leonard, W.J. (1995). Regulation of cell-type-specific interleukin-2 receptor α chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-κB family proteins. Mol. Cell. Biol. 15, 1786-1796.
25. Johnson, K.R., Disney, J.E., Wyatt, C.R., and Reeves, R. (1990). Expression of mRNAs encoding mammalian chromosomal proteins HMG-I and HMG-Y during cellular proliferation. Exp. Cell Res. 187, 69-76.
26. Kontgen, F., Grumont, A.S., Strasser, A., Metcalf, D., Ruili, L, Tarlington, D., and Gerondakis, S. (1995). Mice lacking the c-rel protooncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9, 1965-1977.
27. Kuczek, E.S., Shannon, M.F., Pell, L.M., and Vadas, M.A. (1991). A G-CSF promoter element responsive to inflammatory mediators is functionally distinct from an identical sequence in the GM-CSF gene. J. Immunol. 146, 2426-2433.
28. Kunsch, C., Ruben, S.M., and Rosen, C.A. (1992). Selection of optimal κB/Rel DMA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol. Cell. Biol. 12, 4412-4421.
29. Lai, J.-H., Horvath, G., Subleski, J., Bruder, J., Ghosh, P., and Tan, T.-H (1995). RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter. Mol. Cell. Biol. 15, 4260-4271.
30. Lederer, J.A., Liou, J.S., Todd, M.D., Glimcher, L.H., and Lichtman, A.H. (1994). Regulation of cytokine gene expression in T helper cell subsets. J. Immunol. 152, 77-86.
31. Lenschow, D.J., Zeng, Y., Thistlethwaite, J.R., Montag, A., Brady, W., Gibson, M.G., Linsley, P.S., and Bluestone, J.A. (1992). Longterm survival of xenogeneic pancreatic islet grafts induced by CTLA-4lg. Science 257, 789-792.
32. Lewis, H., Kaszubska, W., DeLamarter, J.F., and Whelan, J. (1994). Cooperativity between two NF-κB complexes, mediated by high-mobility-group protein I(Y), is essential for cytokine-induced expression of the E-selectin promoter. Mol. Cell. Biol. 14, 5701-5709.
33. Li, M., and Siekevitz, M. (1993). A cis element required for the induction of the interleukin 2 enhancer by human T-cell leukaemia virus type 1 binds a novel tax-inducible nuclear protein. Mol. Cell. Biol. 13, 6490-6500.
34. Linsley, P.S., Wallace, P.M., Johnson, J., Gibson, M.G., Greene, J.L., Ledbetter, C.S., Singh, C., and Tepper, M.A. (1992). Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257, 792-794.
35. Mattila, P.S., Ullman, K.S., Fiering, S., Emmel, E.A., McCutcheon, M., Crabtree, G.R., and Herzenberg, L.A. (1990). The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J. 9, 4425-4433.
36. McCaffrey, P.G., Jain, J., Jaimieson, C., Sen, R., and Rao, A. (1992). A T cell factor resembling NF-AT binds to an NF-κB site and to the conserved lymphokine promoter sequence "cytokine-1." J. Biol. Chem. 267, 1864-1871.
37. Nissen, M.S., Langan, T.A., and Reeves, R. (1991). Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein. J. Biol. Chem. 266, 19945-19952.
38. Nordeen, S.K. (1988). Luciferase reporter vectors for analysis of promoters and enhancers. Biotechniques 6, 454-458.
39. Reeves, R., and Nissen, M.S. (1990). The A:T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. J. Biol. Chem. 265, 8573-8582.
40. Rincon, M., and Flavell, R.A. (1994). AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 13, 4370-4381.
41. Rooney, J.W., Sun, Y.-L., Glimcher, L.H., and Hoey, T. (1995). Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol. Cell. Biol. 15, 6299-6310.
42. Rudd, C.E., Janssen, O., Cai, Y.-C., da Silva, A.J., Raab, M., and Prasad, K.V.S. (1994). Two step TCR/CD3-CD4 and CD28 signaling in T-cells: SH2/SH3 domains, protein-tyrosine and lipid kinases. Immunol. Today 15, 225-234.
43. Schreiber, E., Matthias, P., Muller, M.M., and Schaffner, W. (1989). Rapid detection of octamer binding proteins with 'mini extracts', prepared from a small number of cells. Nucl. Acids Res. 17, 6419.
44. Schwartz, R.H. (1992). Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in IL-2 production and immunotherapy. Cell 71, 1065-1068.
45. Serfling, E., Avots, A., and Neamann, M. (1995). The architecture of the interleukin 2 promoter: a reflection of T lymphocyte activation. Biochim. Biophys. Acta 1263, 181-200.
46. Shannon, M.F., Pell, L.M., Lenardo, M.J., Kuczek, E.S., Occhiodoro, F.S., Dunn, S.M., and Vadas, M.A. (1990). A novel tumour necrosis factor-responsive transcription factor which recognizes a regulatory element in hemopoietic growth factor genes. Mol. Cell. Biol. 10, 2950-2959.
47. Thanos, D., and Maniatis, T. (1992). The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell 71, 777-789.
48. Thanos, D., and Maniatis, M. (1995). Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell 83, 1091-1100.
49. Thompson, C.B., Lindsten, T., Ledbetter, J.A., Kunkel, S.L., Young, H.A., Emerson, S.G., Leiden, J.M., and June, C.H. (1989). CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 86, 1333-1337.
50. Verweij, C.L., Geerts, M., and Aarden, L.A. (1991). Activation of interleukin 2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB-like response element. J. Biol. Chem. 266, 14179-14182.
51. Walunas, T.L., Lenschow, D.J., Bakker, C.Y., Linsley, P.S., Freeman, G.J., Green, J.M., Thompson, C.B., and Bluestone, J.A. (1994). CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413.
52. Weiss, A., and Littman, D.R. (1994). Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274.
53. Weiss, A., Imboden, J.B., Hardy, K., and Stobo, J. (1987). The role of the antigen receptor/T3 complex in T-cell activation. Adv. Exp. Med. Biol. 213, 45-49.
54. Wood, K.V. (1991). Chemiluminescence: Current Status, P. Stanley and L. Cricka, eds. (Chichester, England: John Wiley and Sons, Ltd.), p. 543.